Cubist Systematic Strategies, LLC Catalent, Inc. Call Options Transaction History

Cubist Systematic Strategies, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	SELL	$42.56 - $59.82 $259,616 - $364,902	-6,100 Reduced 43.88%	7,800 $440,000
Q4 2023 Feb 14, 2024	BUY	$32.18 - $46.57 $19,308 - $27,942	600 Added 4.51%	13,900 $624,000
Q3 2023 Nov 14, 2023	BUY	$44.2 - $50.2 $587,860 - $667,660	13,300 New	13,300 $605,000
Q1 2023 May 15, 2023	BUY	$45.44 - $74.26 $227,200 - $371,300	5,000 New	5,000 $328,000

489

165M

364K

837K

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.9B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.